TPST — Tempest Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- $34.53m
- $14.06m
- 24
- 16
- 33
- 14
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -44.6 | -36.4 | -28.3 | -35.7 | -29.5 |
Depreciation | |||||
Non-Cash Items | 5.3 | 5.52 | 2.68 | 2.88 | 4.45 |
Other Non-Cash Items | |||||
Changes in Working Capital | -2.05 | 0.296 | -0.705 | 1.12 | -2.69 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -41.2 | -30.4 | -26 | -31.1 | -27.4 |
Capital Expenditures | -0.397 | -0.026 | -0.135 | -0.562 | -0.17 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 4.38 | 0 | 0.038 | 0 | — |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 3.99 | -0.026 | -0.097 | -0.562 | -0.17 |
Financing Cash Flow Items | 0 | — | 10.5 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 26.9 | 5.39 | 59.1 | 11.4 | 35.6 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -10.3 | -24.9 | 33 | -20.2 | 8.07 |